Pharmaceutical Executive examines 503B outsourcing role in drug supply gaps
The piece looks at what outsourcing facilities and compounding pharmacies actually do when commercial products run short.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 14 07:49 ETSource: Pharmaceutical Executive
The wire
- 01Pharmaceutical Executive published an item on the role 503B outsourcing facilities and compounding pharmacies play in filling supply gaps.
- 02Compounders have been central to peptide and incretin access during shortages, and the scope of what 503B facilities may legally produce shapes clinic and telehealth sourcing.
- 03Details of the arguments and any data cited are not available in the item as distributed.
From the source
Read at pharmexec.comThe Role That 503B Outsourcing and Compounding Pharmacies Actually Play in Filling Supply Gaps
